HeartLung.AI

Risk assessment and decision support tools to support preventive healthcare, early detection and monitoring of diseases.

Book a meeting

Company Overview

HeartLung.AI is focused on personalized preventive healthcare for early detection and monitoring of heart disease, lung cancer, osteoporosis, and fatty liver disease using a regular non-contrast chest CT scan read by AI and approved by radiologists.

HeartLung.AI has received FDA approval for their AutoBMD solution and is pending 510k approval for AutoCAC and AutoChamber that aims to enhance traditional coronary artery calcium scoring.

Their AutoChamber tool achieved FDA Breakthrough Device Designation.

 

HeartLung-1

Modalities

ct-icon-2-150x150

Subspecialties

MSK-icon-150x150
Cardiology-icon-150x150

Applications available

To find out more about this solution or any of the other 140+ applications on the Blackford Platform, please book a discovery call with our team.

review image 1

Book a meeting

We’d welcome the opportunity to learn more about your AI needs and to explain how partnering with Blackford can drive efficiency and provide ongoing value.

Book a Meeting